Page 1 of Clinical Trials for Peptide Vaccine, 400 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Active, not recruiting
Adjuvant Therapy of Pegylated Interferon- 2b Plus Melanoma Peptide Vaccine
Last Updated: April 24, 2012
Condition(s): Melanoma
2
Completed
MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma
Last Updated: June 29, 2011
Condition(s): Melanoma; Metastases
3
Recruiting
Trial of a WT-1 Analog Peptide Vaccine in Patients With Acute Myeloid Leukemia (AML) or Acute Lymphoblastic Leukemia (ALL)
Last Updated: March 13, 2012
Condition(s): Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia
4
Recruiting
PSMA and TARP Peptide Vaccine With Poly IC-LC Adjuvant in HLA-A2 (+) Patients With Elevated PSA After Initial Definitive Treatment
Last Updated: January 11, 2012
Condition(s): Prostate Cancer
5
Completed
A Phase I/II Safety and Immunogenicity Trial of UBI Microparticulate Monovalent (HIV-1 MN) Branched Peptide Vaccine in HIV-1 Seronegative Human Subjects
Last Updated: June 23, 2005
Condition(s): HIV Infections
6
Recruiting
Antiangiogenic Peptide Vaccine Therapy in Treating Patient With Hepatocellular Carcinoma
Last Updated: December 23, 2010
Condition(s): Hepatocellular Carcinoma
7
Active, not recruiting
HLA-A*0201 Restricted Peptide Vaccine Therapy With Gemcitabine With Gemcitabine in Patient Pancreatic Cancer (Phase1)
Last Updated: December 23, 2010
Condition(s): Pancreatic Cancer
8
Completed
A Phase I Trial of HIV-1 C4-V3 Polyvalent Peptide Vaccine in HIV-1 Infected Persons
Last Updated: October 25, 2005
Condition(s): HIV Infections
9
Completed
Phase II Study of Immunization With a Hepatitis C Virus (HCV) Antigen Peptide Vaccine
Last Updated: January 15, 2008
Condition(s): Chronic Hepatitis C
10
Completed
A Phase I Safety and Immunogenicity Trial of UBI SynVac (HIV-1 MN Octameric V3 Peptide Vaccine)
Last Updated: June 23, 2005
Condition(s): HIV Infections
11
Completed
Injection Of AJCC Stage IIB, IIC, III And IV Melanoma Patients With A Multi-Epitope Peptide Vaccine Using GM-CSF DNA As An Adjuvant: A Pilot Trial To Assess Safety And Immunity
Last Updated: June 9, 2011
Condition(s): Melanoma
12
Not yet recruiting
Cyclophosphamide and Vaccine Therapy in Treating Patients With Stage II-III Breast, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Last Updated: May 24, 2012
Condition(s): Recurrent Breast Cancer; Recurrent Fallopian Tube Cancer; Recurrent Ovarian Epithelial Cancer; Recurrent Ovarian Germ Cell Tumor; Recurrent Primary Peritoneal Cavity Cancer; Stage IIA Ovarian Epithelial Cancer; Stage IIA Ovarian Germ Cell Tumor; Stage IIA Primary Peritoneal Cavity Cancer; Stage IIB Ovarian Epithelial Cancer; Stage IIB Ovarian Germ Cell Tumor; Stage IIB Primary Peritoneal Cavity Cancer; Stage IIC Ovarian Epithelial Cancer; Stage IIC Ovarian Germ Cell Tumor; Stage IIC Primary Peritoneal Cavity Cancer; Stage IIIA Breast Cancer; Stage IIIA Ovarian Epithelial Cancer; Stage IIIA Ovarian Germ Cell Tumor; Stage IIIA Primary Peritoneal Cavity Cancer; Stage IIIB Breast Cancer; Stage IIIB Ovarian Epithelial Cancer; Stage IIIB Ovarian Germ Cell Tumor; Stage IIIB Primary Peritoneal Cavity Cancer; Stage IIIC Breast Cancer; Stage IIIC Ovarian Epithelial Cancer; Stage IIIC Ovarian Germ Cell Tumor; Stage IIIC Primary Peritoneal Cavity Cancer
13
Recruiting
Pilot Trial of a WT-1 Analog Peptide Vaccine in Patients With Myeloid Neoplasms
Last Updated: February 20, 2012
Condition(s): Leukemia
14
Recruiting
Randomized Study of Adjuvant WT-1 Analog Peptide Vaccine in Patients With Malignant Pleural Mesothelioma (MPM) After Completion of Combined Modality Therapy
Last Updated: March 8, 2012
Condition(s): Malignant Pleural Mesothelioma
15
Terminated
PR1 Vaccination in Myelodysplastic Syndrome (MDS)
Last Updated: March 17, 2011
Condition(s): Leukemia; Myelodysplastic Syndrome
16
Active, not recruiting
Vaccine Therapy in Preventing Cytomegalovirus in Healthy Participants
Last Updated: April 16, 2012
Condition(s): Nonneoplastic Condition
17
Completed
Vaccine Therapy Plus Immune Adjuvant in Treating Patients With Chronic Myeloid Leukemia, Acute Myeloid Leukemia, or Myelodysplastic Syndrome
Last Updated: February 28, 2012
Condition(s): Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
18
Completed
A Phase I Study of gp100 Human Melanoma Peptide Vaccine With Incomplete Freund's Adjuvant
Last Updated: March 3, 2008
Condition(s): Melanoma
19
Completed
Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Gastric Cancer
Last Updated: April 4, 2012
Condition(s): Gastric Cancer
20
Completed
p53 Synthetic Long Peptides Vaccine With Cyclophosphamide for Ovarian Cancer
Last Updated: February 24, 2011
Condition(s): Ovarian Cancer

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Peptide+Vaccine

Page 1 of Clinical Trials for Peptide Vaccine, 400 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About